We have previously shown that insulin suppresses growth hormone (GH) messenger (m) RNA levels in rat pituitary cells. To further delineate the molecular mechanism of insulin action, the effect of insulin treatment on GH gene transcription rates was examined in GH3 pituitary cells grown in serum-free defined medium. A transcriptional run-off assay was performed when intact isolated nuclei were allowed to continue RNA synthesis in an in vitro reaction. Specific incorporation of V2PIGTP into RNA was quantified by hybridization to rat GH complementary (c) DNA. Hybridization efficiency was measured with an internal I3HlcRNA standard and ranged from 30 to 48%. Alpha-amanitin (1 ;g/ml) inhibited total transcription, and excess unlabeled rat pituitary mRNA (250 ng) competitively inhibited GH mRNA hybridization by >80%. Insulin (0.7 nM) inhibited new GH mRNA synthesis, and maximal inhibition (30% of control) was observed with 7 nM insulin after 4 h treatment. The inhibitory effects of insulin on new GH mRNA synthesis were abolished by both insulin-receptor-antiserum and by guinea-pig anti-insulin serum. The results show that insulin exerts a rapid suppression of new GH mRNA synthesis. These data provide evidence for the direct transcriptional regulation of the GH gene by insulin.
Introduction
Insulin action at the cellular level includes rapid metabolic effects and relatively slower effects on gene expression and protein synthesis (1, 2) . Insulin directly inhibits the transcription of the phosphoenolpyruvate carboxykinase (PEPCK) gene (3) , and stimulates albumin gene transcription (4) . Furthermore, insulin has been shown to regulate the level of several specific messenger RNAs including those for amylase (5) , tyrosine aminotransferase (6) , fatty acid synthetase (7), pyruvate kinase (8) , alpha 2,g globulin (9) , growth hormone (GH)' (10, 1 1), and glyceraldehyde-3-phosphate dehydrogenase (12) .
The hypothalamic regulation of pituitary GH secretion is mediated by growth hormone releasing hormone (GHRH) and somatostatin (13) . GHRH stimulates GH secretion, and somatostatin inhibits GH secretion. Peripheral hormones, includ-ing T3 (14) , hydrocortisone (15, 16) , and insulin-like growth factor-I (17) have also been shown to modulate GH messenger (m) RNA levels. Both T3 and hydrocortisone exert a direct transcriptional effect on GH gene expression (18) (19) (20) (21) . Although insulin has been shown to inhibit GH secretion and GH mRNA levels in GH3 rat pituitary tumor cells (10, 22) , and in normal rat pituitary cells (11) , it is unclear whether the inhibitory effects ofinsulin occur at the level ofGH gene transcription or whether they are in fact posttranscriptional. The suppression of GH mRNA levels by insulin may be due to a direct inhibition of GH gene transcription, as has been demonstrated for the PEPCK gene (4) . Alternatively, a more distal effect of insulin on GH gene expression appears possible because insulin has been shown to inhibit induction of GH mRNA levels by T3 and hydrocortisone in GH3 (10) and by GHRH in normal pituitary cells (1 1) . The net decrease of GH mRNA by insulin may reflect a decrease in GH gene transcription rates, or changes in GH mRNA processing, transport, or degradation (23).
Therefore, to clarify the inhibitory mechanism ofinsulin on GH gene expression, we examined the effects of insulin on new GH mRNA synthesis in GH3 rat pituitary cells in a nuclear runoff transcription assay. These cells were chosen because they have been extensively studied as models for GH gene regulation by other hormones (18) (19) (20) (21) . They have also been found to be responsive to physiological levels of insulin in inhibiting GH secretion and mRNA levels (10, 22) , and have recently been shown to contain relatively high levels of insulin receptors (24) (25) (26) . The results shown here indicate that insulin directly regulates the transcriptional activity of the GH gene in these cells.
15 strokes) in a glass homogenizer (Dounce, Millville, NJ) fitted with a tight pestle. The homogenate was diluted with 2 vol of 2 M sucrose, 5 mM magnesium acetate, 0.1 mM EDTA, 10 mM Tris HCI, pH 8.0, and I mM DTT, and then layered over a 10-ml cushion of the 2 M sucrose buffer, and centrifuged at 30,000 g for 45 min, at 4VC. After decanting, the nuclei were resuspended in 100-200 Ml of 25% glycerol, 5 mM Mg acetate, 5 mM DTT in 0.1 mM EDTA, 50 mM Tris HCI, pH 8.0. All buffers contained inhibitors of endogenous nucleases and proteases (0.1 mM phenylmethylsulfonyl fluoride, 1 mM EGTA, and I mM spermidine).
Synthesis of radiolabeled RNA in isolated nuclei. Nuclei were incubated with ATP, CTP, and UTP (2 mM each), 0.2 mM GTP, 0.1 mM S-adenosylmethionine, and [32P]guanosine 5'-triphosphate (800 Ci/mmol, 20 Ml) in 0.15 M KCI and 3 mM Mg acetate (28) . The transcription reaction, in a total volume of 200 Ml, was continued for 45 min at 25°C. 10 volumes (2.0 ml) of 1% sodium dodecyl sulfate (SDS) in 10 mM EDTA, pH 7.0 was added to stop the reaction, and mixed well. This lysed the nuclei and resulted in a clear viscous solution.
Extraction ofRNA. After the transcription reaction was stopped onetenth (200 Ml) of 3 M sodium acetate, pH 5.0 was added and mixed. An equal volume of 2.5 ml phenol-chloroform (2:1) was then added and mixed well. The mixture was incubated at 60°C for 15 min, and shaken vigorously several times, cooled on ice and centrifuged at 10,000 g for 10 min at 4°C. The upper aqueous phase was recovered avoiding the interface. This phase was further extracted in 2.5 ml of chloroformisoamylalcohol (24:1). 2.5 vol (7.5 ml) of absolute ethanol was added to the aqueous phase and incubated at -20°C for 16 h to precipitate the RNA. The RNA was recovered by centrifugation at 10,000 g for 20 min at 4°C, the ethanol was decanted, and the RNA (pellet) was rewashed by resuspending the pellet in cold ethanol. Incubation at -70°C for 1 h was followed by reprecipitating the RNA, and centrifuging at 10,000 g for 20 min at 4°C. The ethanol was decanted and the RNA pellet dried under vacuum, and then dissolved in 100 Mul of sterile water. An aliquot (2 Ml) was removed for determining total input cpm (usually 5-10 X 106 cpm). Total radioactivity incorporated into the nuclear RNA was determined by blotting 2-Ml aliquots of the transcription reaction to DE-81 filters, washing with dibasic sodium phosphate, and counting as described (29) .
Quantitation of ['2P]RNA by hybridization to immobilized DNA.
The DNA (rGH & pBR322 plasmid) was denatured by boiling for 5 min, followed by quick cooling on ice. DNA (2 Mg) was spotted onto a nitrocellulose paper (NC) and immobilized in a vacuum minifold. After baking the NC sheet in a vacuum oven at 80°C for 2 h, the paper, cut into strips, was placed in a polyethylene bag with 1 ml prehybridization buffer consisting of 50% deionized formamide, 5 X SSC (1 X SSC equals 0.15 M sodium chloride, 0.015 M sodium citrate), 0.1% SDS, 10 mM Tris HCI pH 7.0, 2 mM EDTA, 5 X Denhardt's solution, denatured salmon sperm DNA (200 Mg/ml), and 5 Mg/ml synthetic poly4A) RNA.
NC was then incubated in a 52°C water bath for 3 h prehybridization. The prehybridization buffer was then replaced with 0.9 ml of fresh prehybridization buffer, and 0.1 ml of the appropriate amount of the [32P]RNA probe (>106 cpm). The bag was carefully sealed, mixed gently but thoroughly, and incubated in a 52°C water bath for 3 d. The labeled RNA was therefore hybridized in 45% formamide against duplicate dots of immobilized rGH cDNA and pBR322 plasmid DNA (28) .
In all experiments, [3HIGH cRNA (1,000 cpm) prepared as described below was also added to the hybridization mixture. This served as an internal standard of hybridization efficiency.
Wash and development. After hybridization, the bag was opened and the NC filter was placed in a tray with 100 ml of 2 X SSC, 0.1% SDS and agitated gently for 10 min at room temperature. This wash procedure was repeated four times. Three further 30-min washes were then performed at 50, 55, and 60°C, respectively, in 0.1 X SDS and 0.1% SSC.
The NC paper from some experiments was blotted with paper towels, dried, and wrapped in Saran wrap and then autoradiographed. X-ray film was exposed at -70°C, using intensifying screens, for Preparation ofpituitary mRNA. In order to prepare large amounts of unlabeled mRNA to be used for competition of hybridization, rat pituitary polyadenylated(polyA)RNA was prepared. 10 rat pituitary glands were collected after decapitation. Total RNA was extracted using guanidinium isocyanate and hot phenol (30) . Poly(A)RNA was obtained by chromatography over oligo (dT) cellulose columns (31) . 226 Mg of total pituitary RNA yield 6 ug of poly(A)RNA.
GH cDNA insert preparation. 50 ;ig ethanol precipitable plasmid (4,362-nucleotide pBR322 vector containing 800-nucleotide rGH cDNA insert kindly provided by Dr. John Baxter and Dr. Norman Eberhardt, University of California, San Francisco [32] ) was digested with Hind III (0.6 U/ml) and incubated with 50 mM NaCl, 10 mM Tris HC1 (pH 7.5), 10 mM MgCl2, 1 mM DTT for 2 h at 37°C. After digestion, the plasmid was electrophoresed on a 1% agarose gel in 0.089 M Tris-borate, 0.089 M boric acid, 2 mM EDTA pH 8.0 containing 0.5 Mg/ml ethidium bromide. After minigel electrophoresis, the 800-basepair (bp) insert was collected on NE-45 strip paper (0.45 Mm; Schleicher & Schuell, Inc., Keene, NH) and eluted with phenol. After ethanol precipitation, the insert was reprecipitated with 0.3 M sodium acetate to remove the NaCl residue. The cDNA plasmid insert for rat PRL (33) was kindly provided by Dr. John Baxter and the plasmid was propagated as described (34) .
3H-labeled GH cRNA preparation. The following modifications of the method ofMcKnight and Palmiter (35) were used to isolate [3H]GH cRNA. GH cRNA was obtained from the Hind III digested GH cDNA insert using Escherichia coli RNA polymerase (New England Nuclear, Boston, MA). 2 Mg of this DNA were suspended in 25 Ml of reaction buffer containing a final concentration of 40 mM Tris, HCI pH 8.0, 10 mM MgCl2, 1 mM DTT, 1 mM K2HPO4, 50 mM KCl, 10% glycerol, 0.5 mM each of GTP, CTP, and ATP, and 300 U/ml E. coli RNA polymerase, and 0.1 mCi of evaporated [3H]UTP (33.7 Ci/mmol, New England Nuclear). The reaction mixture was incubated at 37°C for 2 h, diluted with 200 ,l of DNase buffer (20 mM Hepes, pH 7.5, 5 mM Mg C12, 1 mM CaCl2, 1 mM MnCl2) and digested at 37°C for 60 min with 10 Mg/ml of DNase I (Bethesda Research Laboratories, Gaithersburg, MD). The DNase was removed by adding 20 Ml of 10% SDS, 50 mM EDTA, 100 mM Tris HCG, and 10Mug ofproteinase K (Boehringer Mannheim Diagnostics, Inc., Houston, TX) followed by a 60-min incubation at 37°C. After adding 10 Mg ofE. coli tRNA as carrier, phenol/chloroform (1:1) extraction was performed. After two chloroform extractions, the RNA was recovered by ethanol precipitation (-20°C, overnight). The pellet was dissolved in 500 Ml of gel buffer (0.3 M NaCI, 0.1% SDS, 1 mM EDTA, 10 mM Tris HCG pH 7.5). The labeled cRNA was purified by chromatography on a column (0.5 X 10 cm) of Sephadex G-50 and the RNA was recovered by ethanol precipitation. The final pellet was dissolved in 1 ml of 20 mM Tris HCl pH 8.0, 50 mM NaCl, 6 mM MgCI2, and stored at -20°C until used.
Materials. Insulin receptor antiserum (B9) was kindly provided by Dr. Ron Kahn, Joslin Clinic, Boston, MA. This antiserum is specific for the insulin receptor (33) , and has been shown to inhibit the suppressive effect of insulin on pituitary GH mRNA levels (11) . Guinea 
Results

RNA synthesis in isolated nuclei
The nuclear run-off assay was performed as a reflection of in vitro GH gene transcription. 107 cells were harvested after 4 h incubation in serum-free medium with or without added insulin (0.7, 3.5, and 7 nM, respectively). Nuclei were then isolated and incubated in the transcription reaction. The time course of the incorporation of total radioactive GTP into the isolated nuclei is shown in Fig. 1 48 h, no differences in inhibition of GH gene transcription were seen. Time course. GH3 cells were incubated in serum-free medium with or without added insulin (7 nM) for 1-72 h. At each time point, medium was aspirated and the nuclei were immediately isolated for assay of GH transcriptional activity. For each time point, new mRNA synthesis was measured in control untreated cells, and in insulin-treated cells. As shown in Fig. 3 Specificity ofthe insulin effect. The specificity of inhibitory effect of insulin on GH gene transcription was tested by using a guinea pig anti-insulin serum (Fig. 4) . The antiserum (1:2,000) was added to the cultures 1 h before insulin treatment. Cells in control wells were also exposed to similar titers of nonimmune guinea pig serum. After 4 h treatment, isolated nuclei were subjected to the transcriptional runoff assay. At that time, not only new GH mRNA, but also prolactin mRNA synthesis were measured by hybridization against both immobilized GH cDNA and prolactin cDNA (2 ig/dot each), respectively. Insulin (7 nM) did not alter new PRL mRNA synthesis, although GH mRNA synthesis was clearly inhibited by insulin in the same cells by -75%. Anti-insulin serum alone did not alter the rate of new GH mRNA synthesis, but did prevent the inhibitory effects of insulin on GH gene transcriptional activity.
To further test the specificity of the insulin effect, we incubated cells in the presence of insulin receptor antiserum (B9). As shown in Fig. 5 , this serum (final titer, 1:4,000) also prevented the insulin-induced suppression of new GH mRNA synthesis. In this experiment, control cells were incubated with equivalent aliquots of nonimmune human serum. Furthermore, treatment of these cells with fibroblast growth factor (FGF) or epidermal growth factor (EGF) (50 ng/ml each, respectively) did not alter the transcriptional activity of the GH gene. During all these control experiments, insulin itself (7 nM) consistently inhibited new GH mRNA synthesis.
Discussion
The roles of insulin, insulin growth factor (IGF)-I and IGF-I1 in regulating GH secretion have recently received increasing attention. It has been suggested, by analogy with the thyroid (37, 38) and adrenal axes (39) , that these related peptides exert a negative feedback effect on rat pituitary (17, (40) (41) (42) (43) (44) 45) and human pituitary (46) GH secretion. The data presented here further extend this hypothesis by delineating a molecular mechanism for the inhibition of GH gene expression by insulin. The results reported here indicate that semisynthetic purified insulin directly regulates the synthesis of nascent GH mRNA chains in GH3 rat pituitary cells. When isolated GH3 cell nuclei were allowed to continue RNA synthesis in vitro, the rates of specific incorporation of radiolabeled RNA precursor into GH mRNA, reflect GH gene transcription rates as far as is possible to determine (28) . This approach is currently the most effective experimental approach to establish that insulin exerts a direct transcriptional effect on the GH gene. The transcriptional runoff assay was specific inasmuch as transcription rates were totally inhibited by alpha-amanitin, a known inhibitor of RNA polymerase activity (47) . Furthermore, excess cold unlabeled mRNA extracted from rat pituitary tissue was able to competitively inhibit the control transcription rates.
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Specific, high affinity receptors for insulin, IGF-I, and IGF-II have been characterized on GH rat pituitary tumor cells (24) (25) (26) , as well as in normal rat pituitary cells (48) (49) (50) . The observed dissociation constant (KD) for insulin binding sites ranged from 0.1 to 5 nM and these insulin receptor sites appeared to be the predominant receptor of these three peptides in the GH3 cells. The relatively low doses of insulin used in these experiments (0.7 to 7 nM) are unlikely to have activated an IGF-I receptor on these cells. The effects of insulin in these experiments were also inhibited by an insulin receptor antiserum (B9) which does not block the IGF-I receptor (36) , further indicating the specificity of the insulin effect. We have previously shown that this titer of antiserum blocks the inhibitory effects of insulin on GH secretion by normal pituitary cells (11) . >200 nM insulin was required for 50% displacement of 2'51-IGF-I from its binding sites on pituitary cells (49) and GH3 cells (26). In another study, only 16% displacement of '251-IGF-I from pituitary cell membranes occurred with exposure to >40 nM insulin (50). Nevertheless, the possibility that even the low doses of insulin used here activated an IGF-I receptor cannot be definitively excluded.
Although insulin (7 nM) maximally inhibits the long-term GH secretion by GH3 cells, far higher (-32 nM) concentrations of a partially purified somatomedin preparation were required to elicit maximal suppression of GH secretion (22) . Because of this relative insensitivity of the GH3 cells to somatomedin, IGF-I was not tested in this model, but was preferably tested in a transcriptional assay in normal pituitary cells. We recently observed that a recombinant human IGF-I analog (Amgen, Thr 59) directly inhibits GH gene transcriptional activity in monolayer cultures of normal rat pituitary cells (45) . Although the dose response was similar, the time course of the IGF-I effect on GH gene transcription appears to differ from that of insulin reported here, albeit in a different model. 1.3 nM IGF-I suppressed new GH mRNA synthesis, and this suppression of transcription lasted for at least 24 h. The maximal insulin effect, however, was seen here after 4 h, and GH transcriptional rates began recovering thereafter. The inhibitory effects of insulin were also blocked by co-incubation of cells with anti-insulin serum at similar titers (1:2,000) previously shown to abolish the effects of insulin on GH secretion by these cells (22) .
Further lines of evidence suggest that the observed effects of insulin in these cells is specific. Insulin did not suppress PRL gene transcriptional activity in these cells, which suggests a selective inhibition of new GH mRNA synthesis. Thus, the above evidence suggests that insulin specifically regulates the transcriptional activity of the GH gene.
Insulin was shown to regulate carbohydrate metabolism (51), and total protein synthesis (52) in rat anterior pituitary tissue. Subsequently, the direct effects of insulin on in vitro expression of GH have been examined by several groups (10, 11, 40, (53) (54) (55) (56) . Using several different systems, and differing preparations of insulin, the results of most studies have shown that insulin suppresses the secretion of GH by both GH3 cells and normal pituitary cells. Furthermore, insulin has also been shown to inhibit the levels of GH mRNA transcripts in GH3 (10) and normal rat pituitary cells (11) . These effects were observed at insulin doses within the physiologic range and occurred independently ofthe presence of glucose or serum. Furthermore, the suppressive effect of insulin on GH appears to be selective, inasmuch as PRL (22) , follicle-stimulating hormone, and luteinizing hormone secretion appear to be mildly stimulated by insulin (57) . The data presented here indicate that the mechanism for these observed effects of insulin on GH gene expression involve a direct inhibition of GH transcriptional rates induced by insulin. This observation is further evidence for a specific role of insulin in the pituitary cellular regulation of GH secretion.
The inhibition of GH gene transcription by insulin occurs earlier than the inhibition of GH mRNA levels and subsequent hormone secretion by these cells. The reversal of insulin inhibition of the GH transcription rate between 4 and 72 h may be due to desensitization of the response or possibly to insulin degradation. Radioimmunoassayable GH secretion is inhibited by insulin in these cells after a lag-period of 24-48 h (22) , GH mRNA levels also fall by 40% after 48 h insulin treatment reaching 50% of control untreated mRNA levels by 72 h. The early 50% suppression of GH transcription, seen after 4 h, followed by a later suppression of mRNA levels and hormone secretion seen after 48 h, is consistent with the reported 40-56-h half-life of GH mRNA in these cells (20 (17) , and this inhibition also appears to occur at the level of GH gene transcription (45) .
These results provide further evidence for the role of insulin in regulating GH gene expression. Although the finding that the hypothalamic content of insulin is significantly higher than in other rat brain regions (60) is consistent with a role for insulin regulation of pituitary function, the physiologic source for pituitary insulin cannot be determined from these in vitro experiments.
The data shown here provide the first evidence for transcriptional regulation of a polypeptide hormone gene by insulin. This observation provides further insight into the molecular mechanism of insulin action at the nuclear level and is consistent with the notion of a direct regulation of GH gene expression by insulin.
